Apollo Hospitals Enterprise Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹4966
- Today's High:
- ₹5127.05
- Open Price:
- ₹5110
- 52W Low:
- ₹4065.402
- 52W High:
- ₹5352.1294
- Prev. Close:
- ₹5094.75
- Volume:
- 6622
Company Statistics
- Market Cap.:
- ₹307.62 billion
- Book Value:
- 225.396
- Revenue TTM:
- ₹107.66 billion
- Operating Margin TTM:
- 4.81%
- Gross Profit TTM:
- ₹37.67 billion
- Profit Margin:
- 1.52%
- Return on Assets TTM:
- 3.01%
- Return on Equity TTM:
- 4.1%
Company Profile
Apollo Hospitals Enterprise Limited had its IPO on under the ticker symbol 508869.
The company operates in the Healthcare sector and Hospitals industry. Apollo Hospitals Enterprise Limited has a staff strength of 62,939 employees.
Stock update
Shares of Apollo Hospitals Enterprise Limited opened at ₹5110 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹4966 - ₹5127.05, and closed at ₹4977.25.
This is a -2.31% slip from the previous day's closing price.
A total volume of 6,622 shares were traded at the close of the day’s session.
In the last one week, shares of Apollo Hospitals Enterprise Limited have increased by +3.2%.
Apollo Hospitals Enterprise Limited's Key Ratios
Apollo Hospitals Enterprise Limited has a market cap of ₹307.62 billion, indicating a price to book ratio of 10.0678 and a price to sales ratio of 2.9516.
In the last 12-months Apollo Hospitals Enterprise Limited’s revenue was ₹107.66 billion with a gross profit of ₹37.67 billion and an EBITDA of ₹9.22 billion. The EBITDA ratio measures Apollo Hospitals Enterprise Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Apollo Hospitals Enterprise Limited’s operating margin was 4.81% while its return on assets stood at 3.01% with a return of equity of 4.1%.
In Q3, Apollo Hospitals Enterprise Limited’s quarterly earnings growth was a negative -30.2% while revenue growth was a negative 2.8%.
Apollo Hospitals Enterprise Limited’s PE and PEG Ratio
- Forward PE
- 38.3142
- Trailing PE
- 192.9549
- PEG
Its diluted EPS in the last 12-months stands at ₹11.754 per share while it has a forward price to earnings multiple of 38.3142 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Apollo Hospitals Enterprise Limited’s profitability.
Apollo Hospitals Enterprise Limited stock is trading at a EV to sales ratio of 3.1634 and a EV to EBITDA ratio of 24.4547. Its price to sales ratio in the trailing 12-months stood at 2.9516.
Apollo Hospitals Enterprise Limited stock pays annual dividends of ₹6 per share, indicating a yield of 0.26% and a payout ratio of 80.8%.
Balance sheet and cash flow metrics
- Total Assets
- ₹139.75 billion
- Total Liabilities
- ₹29.63 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 80.8%
Apollo Hospitals Enterprise Limited ended 2025 with ₹139.75 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹139.75 billion while shareholder equity stood at ₹59.93 billion.
Apollo Hospitals Enterprise Limited ended 2025 with ₹0 in deferred long-term liabilities, ₹29.63 billion in other current liabilities, 718900000.00 in common stock, ₹59.21 billion in retained earnings and ₹9.52 billion in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹13.74 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹23.11 billion.
Apollo Hospitals Enterprise Limited’s total current assets stands at ₹43.53 billion while long-term investments were ₹0 and short-term investments were ₹3.71 billion. Its net receivables were ₹22.41 billion compared to accounts payable of ₹0 and inventory worth ₹4.37 billion.
In 2025, Apollo Hospitals Enterprise Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Apollo Hospitals Enterprise Limited paid ₹0.81 in dividends in 2025.
Other key metrics
- Current Trading Price
- ₹4977.25
- 52-Week High
- ₹5352.1294
- 52-Week Low
- ₹4065.402
- Analyst Target Price
- ₹
Apollo Hospitals Enterprise Limited stock is currently trading at ₹4977.25 per share. It touched a 52-week high of ₹5352.1294 and a 52-week low of ₹5352.1294. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹5033.77 and 200-day moving average was ₹4662.89 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 3136.2% of the company’s stock are held by insiders while 5006.2% are held by institutions.
Frequently Asked Questions About Apollo Hospitals Enterprise Limited
Similar Industry Stocks (Hospitals)
Most Active
Top Gainers
Top Losers
About
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. The company’s healthcare facilities comprise primary, secondary, and tertiary care facilities. Its tertiary care hospitals provide care in approximately 55 specialties, including cardiac sciences, oncology, critical care, neurosciences, orthopedics, gastroenterology, and transplants. The company also provides other services, such as project consultancy, health insurance, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. The company’s footprint includes 10,167 beds, 3,428 pharmacies, and 765 retail healthcare centers. Apollo Hospitals Enterprise Limited was founded in 1979 and is based in Chennai, India.